Heart Rate, Sympathetic Cardiovascular Influences, and The Metabolic Syndrome

Mancia, 2007, The sympathetic nervous system and the metabolic syndrome, J Hypertens, 25, 909, 10.1097/HJH.0b013e328048d004 Palatini, 2006, Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting, J Hypertens, 24, 603, 10.1097/01.hjh.0000217838.49842.1e Grassi, 1998, Baroreflex control of sympathetic nerve activity in essential and secondary hypertension, Hypertension, 31, 68, 10.1161/01.HYP.31.1.68 Grassi, 1995, Sympathetic activation in obese normotensive subjects, Hypertension, 25, 560, 10.1161/01.HYP.25.4.560 Huggett, 2003, Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension, Circulation, 108, 3097, 10.1161/01.CIR.0000103123.66264.FE Goldstein, 1983, Plasma catecholamines and essential hypertension. An analytical review, Hypertension, 5, 86, 10.1161/01.HYP.5.1.86 Young, 1992, Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980, Int J Obes Relat Metab Disord, 16, 959 Grassi, 1999, How to assess sympathetic activity in humans, J Hypertens, 17, 719, 10.1097/00004872-199917060-00001 Vaz, 1997, Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects, Circulation, 96, 3423, 10.1161/01.CIR.96.10.3423 Grassi, 2000, Adrenergic and reflex abnormalities in obesity-related hypertension, Hypertension, 36, 538, 10.1161/01.HYP.36.4.538 Grassi, 2005, Obstructive sleep apnea-dependent and-independent adrenergic activation in obesity, Hypertension, 46, 321, 10.1161/01.HYP.0000174243.39897.6c Grassi, 2003, Effects of hypertension and obesity on the sympathetic activation of heart failure patients, Hypertension, 42, 873, 10.1161/01.HYP.0000098660.26184.63 Julius, 1991, Hyperkinetic borderline hypertension in Tecumseh, Michigan, J Hypertens, 9, 77, 10.1097/00004872-199101000-00012 Grassi, 1998, Heart rate as marker of sympathetic activity, J Hypertens, 16, 1635, 10.1097/00004872-199816110-00010 Gilardini, 2008, Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity, J Hum Hypertens, 22, 75, 10.1038/sj.jhh.1002288 Shigetoh, 2009, Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population, Am J Hypertens, 22, 151, 10.1038/ajh.2008.331 Julius, 1994, Sympathetics, insulin resistance and coronary risk in hypertension: the “chicken and-egg” question, J Hypertens, 12, 495, 10.1097/00004872-199405000-00001 Lee, 2001, Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese, Metabolism, 50, 135, 10.1053/meta.2001.19502 Grassi, 2005, Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome, Diabetologia, 48, 1359, 10.1007/s00125-005-1798-z Quarti-Trevano, 2008, Role of the different components of metabolic syndrome in the pathogenesis of the adrenergic overdrive, High Blood Press Cardiovasc Prev, 15, 197, 10.1007/BF03263681 Straznicky, 2005, Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome, J Clin Endocrinol Metab, 90, 5998, 10.1210/jc.2005-0961 Mancia, 1995, Ambulatory blood pressure normality: results from the PAMELA study, J Hypertens, 13, 1377, 10.1097/00004872-199512000-00003 Mancia, 2005, Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population, Hypertension, 45, 1072, 10.1161/01.HYP.0000165672.69176.ed Mancia, 2007, Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis, Hypertension, 49, 40, 10.1161/01.HYP.0000251933.22091.24 Quarti-Trevano, 2009, Heart rate as marker of sympathetic activity in the metabolic syndrome, J Hypertens, 27 Grassi, 2007, Excessive sympathetic activation in heart failure with obesità and metabolic syndrome: characteristics and mechanisms, Hypertension, 49, 535, 10.1161/01.HYP.0000255983.32896.b9 Li, 2005, Influence of metabolic syndrome on arterial stiffness and its age-related change in young adults: the Bogalusa Heart Study, Atherosclerosis, 180, 349, 10.1016/j.atherosclerosis.2004.12.016 Grassi, 2004, Counteracting the sympathetic nervous system in essential hypertension, Curr Opin Nephrol Hypertens, 13, 513, 10.1097/00041552-200409000-00006 Watanabe, 2004, Improvement of insulin resistance by troglitazone ameliorates cardiac sympathetic nervous dysfunction in patients with essential hypertension, J Hypertens, 22, 1761, 10.1097/00004872-200409000-00021 Redon, 2008, Scientific Council of the European Society of Hypertension. The metabolic syndrome in hypertension: European Society of Hypertension position statement, J Hypertens, 26, 1891, 10.1097/HJH.0b013e328302ca38